Global Medical Response Valuation Multiples

Discover revenue and EBITDA valuation multiples for Global Medical Response and similar public comparables like Gushengtang Holdings, Diagnósticos da América, WELL Health, Saudi German Health and more.

Global Medical Response Overview

About Global Medical Response

GMR Solutions Inc is a holding company, along with its various subsidiaries, that delivers compassionate, quality medical care, meeting a patient's unplanned and planned care needs. The group provides emergent, non-emergent, disaster response, and event medical services across the healthcare ecosystem, serving local communities, health systems, payors, public health, and local, state, and federal agencies within the United States.


Founded

N/A

HQ

United States

Employees

N/A

Financials (LTM)

Revenue: $5.9B
Net Income: -

EV

$5.1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Global Medical Response Financials

Global Medical Response reported last 12-month revenue of $5.9B.

Revenue (LTM)


Global Medical Response P&L

In the most recent fiscal year, Global Medical Response reported revenue of $5.7B and EBITDA of $1.1B.

Global Medical Response is profitable as of last fiscal year, with EBITDA margin of 19% and net margin of 4%.

See analyst estimates for Global Medical Response
LTMLast FY202320242025202620272028
Revenue$5.9B$5.7B$5.4B$6B$5.7B
EBITDA-$1.1B$675M$912M$1.1B
EBITDA Margin-19%13%15%19%
EBIT Margin13%14%8%12%14%
Net Profit-$206M($203M)$20M$206M
Net Margin-4%(4%)0%4%
Net Debt-$4.5B---

Financial data powered by Morningstar, Inc.

Global Medical Response Stock Performance

Global Medical Response has current market cap of $727M, and enterprise value of $5.1B.

Market Cap Evolution


Global Medical Response's stock price is $13.46.

Global Medical Response share price increased by 10.8% in the last 30 days.

Global Medical Response has an EPS (earnings per share) of $3.82.

See more trading valuation data for Global Medical Response
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5.1B$727M0.0%10.8%-12.9%-$3.82

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Global Medical Response Valuation Multiples

Global Medical Response trades at 0.9x EV/Revenue multiple, and 4.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Global Medical Response

EV / Revenue (LTM)


Global Medical Response Financial Valuation Multiples

As of September 7, 2026, Global Medical Response has market cap of $727M and EV of $5.1B.

Global Medical Response has a P/E ratio of 3.5x.

LTMLast FY202320242025202620272028
EV/Revenue0.9x0.9x0.9x0.8x0.9x
EV/EBITDA-4.7x7.5x5.6x4.7x
EV/EBIT6.4x6.1x12.0x7.0x6.1x
P/E-3.5x(3.6x)35.6x3.5x
EV/FCF11.1x13.2x58.4x(225.9x)13.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Global Medical Response Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Global Medical Response Margins & Growth Rates

Global Medical Response grew revenue by 5% and EBITDA by 9% in the last fiscal year.

In the most recent fiscal year, Global Medical Response reported EBITDA margin of 19% and net margin of 4%.

See estimated margins and future growth rates for Global Medical Response

Global Medical Response Margins

Last FY202420252026202720282029
EBITDA Margin19%15%19%19%
EBIT Margin14%12%14%13%
Net Margin4%0%4%5%
FCF Margin7%(0%)7%8%

Global Medical Response Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth5%11%(4%)5%
EBITDA Growth9%35%17%9%
EBIT Growth(7%)71%14%(7%)
Net Profit Growth45%(110%)910%45%
FCF Growth28%(126%)(1808%)28%

Data powered by FactSet, Inc. and Morningstar, Inc.

Global Medical Response Operational KPIs

Global Medical Response's Rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Global Medical Response's Rule of X is 32% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Global Medical Response
Last FY202320242025202620272028
Rule of 4024%---
Bessemer Rule of X32%---
G&A Expenses to Revenue56%56%54%56%
Opex to Revenue87%92%88%87%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Global Medical Response Competitors

Global Medical Response competitors include Gushengtang Holdings, Diagnósticos da América, WELL Health, Saudi German Health, Al-Maidan Dental Clinic, Integral Diagnostics, Hermina Hospitals, Garofalo Health Care, Chularat Hospital and Infracore.

Most Global Medical Response public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Gushengtang Holdings1.6x-8.5x-
Diagnósticos da América0.9x1.0x5.6x4.9x
WELL Health1.4x1.3x12.7x10.1x
Saudi German Health1.8x1.7x7.2x8.8x
Al-Maidan Dental Clinic2.3x-12.4x-
Integral Diagnostics1.8x1.8x10.2x8.5x
Hermina Hospitals2.1x2.0x8.2x7.7x
Garofalo Health Care1.5x1.4x9.9x8.7x

This data is available for Pro users. Sign up to see all Global Medical Response competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Global Medical Response

Where is Global Medical Response headquartered?Global Medical Response is headquartered in United States.
Who is the CEO of Global Medical Response?Global Medical Response's CEO is Nick Loporcaro.
Is Global Medical Response publicly listed?Yes, Global Medical Response is a public company listed on NYSE.
What is the stock symbol of Global Medical Response?Global Medical Response trades under GMRS ticker.
When did Global Medical Response go public?Global Medical Response went public in 2026.
Who are competitors of Global Medical Response?Global Medical Response main competitors include Gushengtang Holdings, Diagnósticos da América, WELL Health, Saudi German Health, Al-Maidan Dental Clinic, Integral Diagnostics, Hermina Hospitals, Garofalo Health Care, Chularat Hospital, Infracore.
What is the current market cap of Global Medical Response?Global Medical Response's current market cap is $727M.
What is the current revenue of Global Medical Response?Global Medical Response's last 12 months revenue is $5.9B.
What is the current revenue growth of Global Medical Response?Global Medical Response revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Global Medical Response?Current revenue multiple of Global Medical Response is 0.9x.
Is Global Medical Response profitable?No, Global Medical Response is not profitable.
What is the current FCF of Global Medical Response?Global Medical Response's last 12 months FCF is $455M.
What is Global Medical Response's FCF margin?Global Medical Response's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of Global Medical Response?Current FCF multiple of Global Medical Response is 11.1x.
How many companies Global Medical Response has acquired to date?Global Medical Response hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Global Medical Response has invested to date?Global Medical Response hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Global Medical Response

Lists including Global Medical Response

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial